|
Volumn 45, Issue 10, 2001, Pages 2845-2855
|
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANIDULAFUNGIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIFUNGAL ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
CANDIDIASIS;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG EFFICACY;
FEMALE;
LUNG ASPERGILLOSIS;
MINIMUM INHIBITORY CONCENTRATION;
MYCOSIS;
NEUTROPENIA;
NONHUMAN;
OPPORTUNISTIC INFECTION;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
RABBIT;
TISSUE DISTRIBUTION;
ANIMALS;
ANTIBIOTICS, ANTIFUNGAL;
ASPERGILLOSIS;
CANDIDIASIS;
DISEASE MODELS, ANIMAL;
FEMALE;
LUNG DISEASES, FUNGAL;
NEUTROPENIA;
OPPORTUNISTIC INFECTIONS;
PEPTIDES, CYCLIC;
RABBITS;
TISSUE DISTRIBUTION;
|
EID: 0034812542
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.45.10.2845-2855.2001 Document Type: Article |
Times cited : (131)
|
References (35)
|